Comparison of efficacy and early surgery-related complications between one-quadrant and two-quadrant microhook ab interno trabeculotomy: a propensity score matched study. 2021

Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.

OBJECTIVE We compared the 1-year outcomes and early surgery-related complications between 1-quadrant and 2-quadrant microhook ab interno trabeculotomy (TLO). METHODS Medical chart extraction was performed on 47 consecutive patients with 1-quadrant incision and 37 consecutive patients with 2-quadrant incision of trabecular meshwork. Logistic regression analysis was conducted to calculate the propensity score to create a 1:1 match for a comparative analysis of 1-year postoperative success. Success was defined as postoperative intraocular pressure (IOP) between 5-21 mmHg, >20% IOP reduction from baseline, and no additional glaucoma surgery. Outcome-related covariates were age, glaucoma type, mean deviation of visual field tests, preoperative IOP, the number of preoperative glaucoma eye drops and the presence of combined cataract surgery. Thirty eyes from each group were compared. RESULTS The median preoperative IOP was not different between the 1-quadrant and 2-quadrant groups (28.5 mmHg, quartile range 23-33.5 versus 27 mmHg, 23.3-30.0, p = 0.47). There was no difference in median postoperative IOP at 1 year (15 mmHg versus 16 mmHg, p = 0.80). The success rate was 73% in the 1-quadrant group versus 70% in the 2-quadrant group (p = 1.00). The 2-quadrant group had a significantly higher proportion of patients with transiently elevated IOP (47%) than the 1-quadrant (17%; Fisher's exact test, p = 0.02). There was no difference of hyphema formation (Fisher's exact test, p = 0.18). CONCLUSIONS The 1-year success rate was not significantly different between 1- and 2-quadrant incisions of microhook TLO. However, the 2-quadrant TLO showed significantly higher proportion of post-surgical transient IOP elevation.

UI MeSH Term Description Entries
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D004867 Equipment Design Methods and patterns of fabricating machines and related hardware. Design, Equipment,Device Design,Medical Device Design,Design, Medical Device,Designs, Medical Device,Device Design, Medical,Device Designs, Medical,Medical Device Designs,Design, Device,Designs, Device,Designs, Equipment,Device Designs,Equipment Designs
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005901 Glaucoma An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) Glaucomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
October 2023, Ophthalmology and therapy,
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
January 2022, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
July 2021, Journal of clinical medicine,
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
January 2018, Clinical ophthalmology (Auckland, N.Z.),
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
January 2022, International journal of ophthalmology,
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
August 2021, Scientific reports,
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
January 2022, Journal of clinical medicine,
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
April 2022, Eye (London, England),
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
December 2023, Journal of clinical medicine,
Sotaro Mori, and Yusuke Murai, and Kaori Ueda, and Mari Sakamoto, and Takuji Kurimoto, and Yuko Yamada-Nakanishi, and Makoto Nakamura
January 2022, Ophthalmology. Glaucoma,
Copied contents to your clipboard!